Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

Front Oncol. 2021 Apr 6:11:670798. doi: 10.3389/fonc.2021.670798. eCollection 2021.

Xiaozhong Liao^{1

2

3}, Ying Gao¹, Jiahui Liu^{1

3}, Lanting Tao¹, Dongmei Wang⁴, Dan Xie², Suilin Mo¹

¹ Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
² The State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
³ Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
⁴ School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2020.01756/full.].

Keywords: DDP; ESCC; NF-κB/COX-2/VEGF pathway; Tan IIA; synergistic effect.